Who owns Delcath Systems'stock?
Delcath Systems' stock is owned by a variety of institutional and retail investors. Top institutional investors include CIBC World Markets Inc. (1. 16%), Susquehanna International Group LLP (0. 37%), State Street Corp (0. 34%) and Virtu Financial LLC (0. 20%).
Is Delcath Systems (Delc) a good buy on Wall Street?
Delcath Systems has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings. According to analysts' consensus price target of $24.33, Delcath Systems has a forecasted upside of 291.2% from its current price of $6.22.
Does Delcath Systems pay a dividend?
Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York. More... DCTH does not currently pay a dividend.
What has Delcath been up since Q3?
Recent Business Highlights During and since the third quarter Delcath: Entered a debt facility with Avenue Venture Opportunities Fund, L.P. providing up to $20 million with an initial $15 million fund Delcath Systems, Inc. (DCTH) Stock Jumps 6.6%: Will It Continue to Soar?
Should I buy or sell Delcath Systems stock right now?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Delcath Systems in the last twelve months. There are currently 2...
What is Delcath Systems' stock price forecast for 2022?
2 equities research analysts have issued 12 month target prices for Delcath Systems' stock. Their forecasts range from $20.00 to $25.00. On average...
How has Delcath Systems' stock price performed in 2022?
Delcath Systems' stock was trading at $7.75 at the beginning of the year. Since then, DCTH shares have decreased by 47.4% and is now trading at $4....
When is Delcath Systems' next earnings date?
Delcath Systems is scheduled to release its next quarterly earnings announcement on Tuesday, August 9th 2022. View our earnings forecast for Delca...
How were Delcath Systems' earnings last quarter?
Delcath Systems, Inc. (NASDAQ:DCTH) announced its earnings results on Tuesday, May, 10th. The company reported ($1.00) EPS for the quarter, missing...
When did Delcath Systems' stock split? How did Delcath Systems' stock split work?
Shares of Delcath Systems reverse split on the morning of Tuesday, October 22nd 2019. The 1-100 reverse split was announced on Friday, October 18th...
Who are Delcath Systems' key executives?
Delcath Systems' management team includes the following people: Mr. Gerard J. Michel MBA , MS, CEO & Director (Age 59, Pay $683.82k) ( LinkedIn...
Who are some of Delcath Systems' key competitors?
Some companies that are related to Delcath Systems include LMF Acquisition Opportunities (LMAO) , iCAD (ICAD) , BrainsWay (BWAY) , Asensus Surg...
What is Delcath Systems' stock symbol?
Delcath Systems trades on the NASDAQ under the ticker symbol "DCTH."
How many shares of Delcath Systems stock are there after the split?
When is the Delcath stock split?
An investor that had 100 shares of Delcath Systems stock prior to the reverse split would have 1 shares after the split.
How much does Delcath make?
Delcath Systems's stock reverse split before market open on Tuesday, October 22nd 2019. The 1-100 reverse split was announced on Friday, October 18th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 21st 2019. An investor that had 100 shares of Delcath Systems stock prior to the reverse split would have 1 shares after the split.
What is the P/E ratio of Delcath Systems?
How much money does Delcath Systems make? Delcath Systems has a market capitalization of $64.25 million and generates $1.16 million in revenue each year. The company earns $-24,160,000.00 in net income (profit) each year or ($8.35) on an earnings per share basis.
Where is Delcath Systems located?
The P/E ratio of Delcath Systems is -2.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
When will Delcath release its next quarterly earnings?
Delcath Systems' mailing address is 1633 BROADWAY SUITE 22C, NEW YORK NY, 10019. The company can be reached via phone at 212-489-2100, via email at [email protected], or via fax at 212-489-2102.
Is Delcath Systems a buy or sell company?
Delcath Systems is scheduled to release its next quarterly earnings announcement on Thursday, August 12th 2021. View our earnings forecast for Delcath Systems.
What is Delcath Systems?
Delcath Systems has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
How much is DCTH revenue in 2020?
(NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announ...
54 Biggest Movers From Yesterday
In 2020, DCTH's revenue was $1.65 million, an increase of 4.18% compared to the previous year's $1.58 million. Losses were -$24.16 million, 172.1% more than in 2019.
36 Stocks Moving In Tuesday's Mid-Day Session
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 66.7% to close at $4.60 on Tuesday. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and accessories.
61 Biggest Movers From Yesterday
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares climbed 123.2% to $6.16. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and accessories.
40 Stocks Moving In Thursday's Mid-Day Session
Gainers Jowell Global Ltd. (NASDAQ: JWEL) jumped 25.5% to close at $13.36. Jowell Global recently announced a collaboration with Unilever's Uni-Excubator.
Transparency is our policy. Learn how it impacts everything we do
Gainers Biofrontera Inc. (NASDAQ: BFRI) surged 39% to $6.02. Biofrontera announced Notice of Allowance for U.S. patent titled 'Illumination for Photodynamic Therapy.'
How we make money
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
How we use your personal data
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.
How we approach editorial content
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
What is Delcath system?
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view.
What is data link?
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
What is market cap?
Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at data.nasdaq.com .
Does market cap include convertible securities?
Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements.
